Skip to content

Biz News Today

Business News – Direct Source News

  • Home
  • Business News Videos
    • International/National News Videos
  • Directory
  • Links PRs
  • REITS
  • About
  • Contact
    • Sitemap

U.S. Food and Drug Administration Accepts for Priority Review Application for Opdivo® (nivolumab) Combined with Chemotherapy as First-Line Treatment in Metastatic Gastric Cancer, Gastroesophageal Junction Cancer and Esophageal Adenocarcinoma

  • Home
  • 2021
  • January
  • 20
  • U.S. Food and Drug Administration Accepts for Priority Review Application for Opdivo® (nivolumab) Combined with Chemotherapy as First-Line Treatment in Metastatic Gastric Cancer, Gastroesophageal Junction Cancer and Esophageal Adenocarcinoma

Original Source

On January 20, 2021

Post navigation

Previous PostMGM Resorts International Sponsors the Las Vegas Dr. Martin Luther King, Jr. Annual Virtual Parade
Next PostBristol Myers Squibb Announces Earnings Call Time Change; Fourth Quarter 2020 Earnings Call to Occur on February 4, 2021 at 10 a.m. (Eastern Time)

Related Post

May 24, 2022
  • Business News
  • Press Release

Apple expands Today at Apple Creative Studios

May 24, 2022
  • Business News

Western Union to Present at the Bernstein Strategic Decisions Conference on June 2nd

May 24, 2022
  • Business News

Incyte to Present at Upcoming Investor Conference

Copyright © All right reserved
Newslist Created By Rise Themes

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home/biznews/public_html/wp-includes/functions.php on line 5219